Clinical Report: Presence of Neutrophil α-defensin-1 in Human Stroke Thrombi

Overview

This study identifies neutrophil α-defensin-1 as a significant component of ischemic stroke thrombi and demonstrates its role in inducing NETosis in vitro. The findings suggest a potential link between neutrophil activity and thrombus composition, which may have implications for stroke management.

Background

Ischemic stroke is a leading cause of mortality and disability, characterized by thrombus formation that obstructs cerebral blood flow. Understanding the composition of stroke thrombi, particularly the role of immune components like neutrophils and NETs, is crucial for developing effective therapeutic strategies. This study highlights the importance of α-defensins in the context of thrombus stability and resistance to treatment.

Data Highlights

Key Findings

• α-Defensin-1 is present in all analyzed ischemic stroke thrombi.
• NETs are a prominent feature of stroke thrombi, contributing to thrombus stability.
• In vitro exposure to α-defensin-1 significantly induces NETosis at a concentration of 10 µg/mL.
• Lower concentrations of α-defensin-1 do not significantly affect NETosis.
• α-Defensin-1 may link neutrophil degranulation to thrombus composition and stability.

Clinical Implications

The presence of α-defensin-1 in stroke thrombi suggests it could be a target for therapeutic interventions aimed at modulating NETosis and improving thrombolytic efficacy. Understanding the role of neutrophil-derived components in thrombus formation may enhance treatment strategies for ischemic stroke.

Conclusion

α-Defensin-1 is a key component of ischemic stroke thrombi that promotes NETosis, indicating its potential role in thrombus stability and resistance to treatment. Further research may elucidate its therapeutic implications.

Related Resources & Content

1. Frontiers in Cardiovascular Medicine, 2026 -- CXCL12 levels correlate with reduced stroke severity and lower risk of hemorrhagic transformation in stroke patients
2. Frontiers in Immunology, 2026 -- Autophagy, NET formation, and inflammation crosstalk in thrombotic autoimmune diseases
3. Basic Research in Cardiology, 2019 -- Neutrophil Extracellular Traps and Fibrocytes in the Context of ST-Segment Elevation Myocardial Infarction
4. Acta Neuropathologica, 2018 -- Inflammation Following Stroke: A Potential Therapeutic Target or a Beneficial Mechanism?
5. American Heart Association, 2026 -- New guideline expands stroke treatment for adults, offers first pediatric stroke guidance
6. New England Journal of Medicine, 2024 -- Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection
7. Frontiers, 2025 -- Neutrophil extracellular traps in ischemic stroke: mechanisms, clinical implications, and therapeutic potential
8. New guideline expands stroke treatment for adults, offers first pediatric stroke guidance | American Heart Association
9. Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection | New England Journal of Medicine
10. Frontiers | Neutrophil extracellular traps in ischemic stroke: mechanisms, clinical implications, and therapeutic potential